Antiperinuclear activity in lung carcinoma patients
- 31 October 1984
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 18 (2) , 80-81
- https://doi.org/10.1007/bf00205738
Abstract
Antiperinuclear factor (APF) might be a specific serum rheumatoid factor directed towards keratohyaline granules. It was found to be present in 40 of 79 (50.6%) patients with primary and in 21 of 36 (58.3%) patients with metastatic lung cancer, compared with 12 of 95 (12.6%) sex- and age-matched normal controls. Additionally, APF frequency and titer correlated well with tumor dissemination, even though no relationship could be shown with histopathological type.Keywords
This publication has 14 references indexed in Scilit:
- Rheumatoid factors in the sera of patients with gastrointestinal carcinomaCancer, 1983
- INVESTIGATIONS OF THE RELATIONSHIP BETWEEN ANTIPERINUCLEAR FACTORS, ANTIKERATIN ANTIBODIES, AND THE AGGLUTINATING AND NON-AGGLUTINATING RHEUMATOID-FACTOR IN RHEUMATOID-ARTHRITIS1983
- Immune complexes and human neoplasia.1983
- The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.Annals of the Rheumatic Diseases, 1979
- Rheumatoid Factor: Correlation with Recurrence in Transitional Cell Carcinoma of the BladderJournal of Urology, 1979
- The Suppressor-Cell Network in CancerNew England Journal of Medicine, 1978
- ANTIBODIES AND ANTI‐ANTIBODIES IN HUMAN MALIGNANCY: AN EXPRESSION OF DERANGED IMMUNE REGULATIONAnnals of the New York Academy of Sciences, 1976
- Rheumatoid factor and tumor-host interaction.Proceedings of the National Academy of Sciences, 1976
- Rheumatoid factor: Its nature, specificity, and production in rheumatoid arthritisClinical Immunology and Immunopathology, 1976
- New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear FactorAnnals of the Rheumatic Diseases, 1964